HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tyler Alban Selected Research

Melanoma (Melanoma, Malignant)

5/2024LRIG1 engages ligand VISTA and impairs tumor-specific CD8+ T cell responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tyler Alban Research Topics

Disease

4Neoplasms (Cancer)
05/2024 - 12/2017
1Melanoma (Melanoma, Malignant)
05/2024
1Triple Negative Breast Neoplasms
10/2023
1Neoplasm Metastasis (Metastasis)
12/2017

Drug/Important Bio-Agent (IBA)

2LigandsIBA
05/2024 - 01/2024
1Immune Checkpoint InhibitorsIBA
05/2024
1EnzymesIBA
01/2024
1PolyaminesIBA
01/2024
1130-nm albumin-bound paclitaxelIBA
10/2023
1pembrolizumabIBA
10/2023
1Carboplatin (JM8)FDA LinkGeneric
10/2023
1Proteoglycans (Proteoglycan)IBA
12/2017
1Versicans (Versican)IBA
12/2017

Therapy/Procedure

3Immunotherapy
05/2024 - 10/2023
1Drug Therapy (Chemotherapy)
10/2023
1Therapeutics
10/2023